AC Immune ( ACIU ) Q2 results (CHF): Revenues: 1.5M (-25.0%). More news on: AC Immune SA, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

AC Immune (NASDAQ: ACIU ): Q2 GAAP EPS of -CHF0.24. More news on: AC Immune SA, Earnings news and commentary, Healthcare stocks news, Read more ...

LAUSANNE, Switzerland, Aug. 14, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, biopharmaceutical company with a broad clinical-stage pipeline focused on neurodegenerative diseases, today announced its business and clinical plan and strategy, reported consolidated finan...